EcoDrugPlus

Monoamine Oxidase A

Ensembl ID : ENSPVAG00000011223
Gene Symbol: MAOA
1 Cross references
146 Possible Orthologues:

Monoamine Oxidase B

Ensembl ID : ENSPVAG00000011226
Gene Symbol: MAOB
1 Cross references
330 Possible Orthologues:

Monoglyceride Lipase

Ensembl ID : ENSPVAG00000005015
Gene Symbol: MGLL
1 Cross references
208 Possible Orthologues:

Myeloperoxidase

Ensembl ID : ENSPVAG00000002318
Gene Symbol: MPO
1 Cross references
181 Possible Orthologues:

Natriuretic Peptide Receptor 1

Ensembl ID : ENSPVAG00000011078
Gene Symbol: NPR1
1 Cross references
184 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSPVAG00000003026
Gene Symbol: NPR2
1 Cross references
259 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSPVAG00000008869
Gene Symbol: NPR3
1 Cross references
211 Possible Orthologues:

Neuropeptide Y Receptor Y5

Ensembl ID : ENSPVAG00000005563
Gene Symbol: NPY5R
1 Cross references
135 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSPVAG00000000509
Gene Symbol: NTSR1
1 Cross references
211 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSPVAG00000007517
Gene Symbol: NTRK1
1 Cross references
199 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSPVAG00000013545
Gene Symbol: NTRK2
1 Cross references
286 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSPVAG00000000439
Gene Symbol: NTRK3
1 Cross references
269 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).